Davao City hits 94.35 % target herd immunity

A total of 1,226,505 Dabawenyos have already been fully vaccinated as of January 21, 2022, making Davao City hit 94.35 percent herd immunity or its target population protection.

The City Government of Davao’s target is to fully vaccinate 1,299,894 individuals, which is about 70 percent of the city’s population.

However, of the 1,226,505 individuals who have received two doses, Mayor Inday Sara Duterte said only 154,267 got their booster shots so far. This means that those who had booster shots only make up 11.87 percent of the target population protection.

The mayor, during her Special Hour program over 87.5 FM Davao City Disaster Radio (DCDR) on January 24, also bared that the city is currently at 98.51 percent of its target for first doses with 1,280,467 individuals catered to.

Of the 63,934 health care workers in the city who were given their first jabs, at least 58,705 received their second doses while 104,331 senior citizens are currently fully inoculated out of the 111,355 who got their first dose shots.

A total of 171,317 adults with comorbidities also completed their two doses of anti-COVID-19 vaccines out of the 188,462 who were administered with initial doses.

At least 3,091 children aged 12 to 17 years old with comorbidities also received two jabs, along with 624,418 essential workers, 122,655 indigents, 29,085 rest of the adult population, and 112,903 rest of the pediatric population.

Meanwhile, Davao City COVID-19 Task Force Dr. Michelle Schlosser earlier urged Dabawenyos to have themselves vaccinated amid the surge of COVID-19 cases in the city.

“Omicron is 10 times more transmissible sya compared to other variants. Ingon ana kapaspas. Dapat 10 times vigilant pud ta kay ang kalaban nato paspas og lihok (The Omicron is 10 times more transmissible than other variants. That’s how fast it is. We need to be 10 times vigilant because our enemy moves so fast),” Schlosser said in a previous interview with DCDR.

She also said that time is of the essence in battling COVID-19.